<p>Kaplan-Meier survival curves in Caucasian- (A and B) and African-Brazilians (C and D) for all-cause death and HF-related death, respectively, according to the <i>MMP-2</i> haplotypes.</p
<p>Kaplan-Meier survival curves for the <i>MTHFR</i> Glu429Ala (overall survival) and the <i>ERCC5</...
<p><i>P</i> value was calculated using a log-rank test. The wildtype alleles, homozygotes, and the c...
<p>Kaplan-Meier survival analysis of CDCS cohort patients stratified by rs6922269 genotype.</p
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) according to <...
<p>No. at risk: blue = homozygote carriers of major allele, green = carriers of minor allele.</p
<p>Panel A represents the overall population; panel B represents the Caucasians only.</p
<p>Kaplan-Meier survival curve for all-cause mortality according to HbA1c levels (%).</p
<p>Kaplan-Meier curves of overall survival of lung cancer patients with different genotypes at intro...
<p>The differences between the groups were statistically significant (p = 0.017 in the derivation gr...
<p>(A) “0” denotes patients with common genotype (AA); “1” denotes patients with AG; “2” denotes pat...
<p>Kaplan-Meier survival curves of patients with wild type (n = 50) vs. mutant (n = 27) <i>K-ras</i>...
<p>Kaplan-Meier curves showing the cumulative proportion of survival patients at 30 days and 6 month...
<p>Using pre-specified contrasts in a Cox regression model adjusted for covariates, differences were...
<p>Kaplan-Meier cumulative survival curves for SAE (HF death, OHT or LVAD) in 46 carriers of <i>TTN<...
<p>Kaplan–Meier curve of overall survival according to (A) <i>XPD Asp<sup>312</sup>Asn</i> polymorph...
<p>Kaplan-Meier survival curves for the <i>MTHFR</i> Glu429Ala (overall survival) and the <i>ERCC5</...
<p><i>P</i> value was calculated using a log-rank test. The wildtype alleles, homozygotes, and the c...
<p>Kaplan-Meier survival analysis of CDCS cohort patients stratified by rs6922269 genotype.</p
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) according to <...
<p>No. at risk: blue = homozygote carriers of major allele, green = carriers of minor allele.</p
<p>Panel A represents the overall population; panel B represents the Caucasians only.</p
<p>Kaplan-Meier survival curve for all-cause mortality according to HbA1c levels (%).</p
<p>Kaplan-Meier curves of overall survival of lung cancer patients with different genotypes at intro...
<p>The differences between the groups were statistically significant (p = 0.017 in the derivation gr...
<p>(A) “0” denotes patients with common genotype (AA); “1” denotes patients with AG; “2” denotes pat...
<p>Kaplan-Meier survival curves of patients with wild type (n = 50) vs. mutant (n = 27) <i>K-ras</i>...
<p>Kaplan-Meier curves showing the cumulative proportion of survival patients at 30 days and 6 month...
<p>Using pre-specified contrasts in a Cox regression model adjusted for covariates, differences were...
<p>Kaplan-Meier cumulative survival curves for SAE (HF death, OHT or LVAD) in 46 carriers of <i>TTN<...
<p>Kaplan–Meier curve of overall survival according to (A) <i>XPD Asp<sup>312</sup>Asn</i> polymorph...
<p>Kaplan-Meier survival curves for the <i>MTHFR</i> Glu429Ala (overall survival) and the <i>ERCC5</...
<p><i>P</i> value was calculated using a log-rank test. The wildtype alleles, homozygotes, and the c...
<p>Kaplan-Meier survival analysis of CDCS cohort patients stratified by rs6922269 genotype.</p